Kangmei Pharmaceutical Co., Ltd. was founded on 1997 by Mr. Ma Xingtian, a private entrepreneur. The company was located in Puning City, Guangdong Province, and was then named "Guangdong Kangmei Pharmaceutical Co., Ltd.". In 2000, the share reform began. It is one of the large-scale private pharmaceutical enterprises integrating pharmaceutical supply and marketing, Chinese herbal pieces, Chinese herbal medicines and medical devices. The company passed the share-trading reform.

In March 2006, 5438+0 Kangmei Pharmaceutical A shares were listed on the Shanghai Stock Exchange. In 2008, Kangmei Pharmaceutical achieved an operating income of 654.38+0.7 billion yuan and a tax profit of 300 million yuan. Kangmei Pharmaceutical has successively passed the chemical drug GMP, traditional Chinese medicine GMP, GSP certification, and ISO 1400 1, ISO900 1, GB\T2800 1 management system certification.

Extended data

Kangmei Pharmaceutical lost 24.48 billion yuan to 29.92 billion yuan:

On the evening of 20021April 16, ST Kangmei, which was already on the verge of delisting, announced that the company had originally expected a net profit loss of 654.38+0.485 billion yuan to 654.38+0.782 billion yuan in the reporting period of 2020, which was attributed to a net profit loss of 24.48 billion yuan to 29.92 billion yuan after revision.

Specifically, ST Kangmei makes provision for impairment of goodwill, accounts receivable, fixed assets, construction in progress and inventory within the scope of the consolidated statements in 2020. Among them, goodwill impairment is about 44 million yuan, credit impairment is about 654.38+0 billion yuan, engineering and fixed assets impairment is about 654.38+0.5 billion yuan, and inventory impairment is about 20.3 billion yuan.

Baidu encyclopedia-kangmei medicine co., ltd